YOD1 and Parkinson disease: Together, these consistent results across acute (6‐OHDA) and chronic (A53T) PD models demonstrate that YOD1 knockdown preserves dopaminergic neurons, maintains DA levels and ameliorates motor deficits through multiple behavioural paradigms, confirming its therapeutic potential for PD intervention.